Cargando…
Bowel Perforation Secondary to Ponatinib Treatment in a Chronic Myelogenous Leukemia Patient: A Case Report
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm of hematopoietic cell origin.It arises from the translocation of chromosomes 9 and 22, with resultant Philadelphia (Ph(+)) chromosome that contains the BCR-ABL1 gene.( )CML has three phases: the chronic phase, the accelerated phase, and...
Autores principales: | Sallam, Asma, Gmati, Giamal Edin, Salman, Refaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719724/ https://www.ncbi.nlm.nih.gov/pubmed/34987886 http://dx.doi.org/10.7759/cureus.19949 |
Ejemplares similares
-
Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017) -
Spontaneous Subgaleal Hematoma in a Sickle Cell Disease Patient: A Case Report
por: Alqurashi, Moayad Majed, et al.
Publicado: (2020) -
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
por: Castagnetti, Fausto, et al.
Publicado: (2021) -
Management of chronic myelogenous leukemia with COVID-19 and hepatitis B
por: Yu, Tian, et al.
Publicado: (2023) -
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib
por: Cassuto, Ophélie, et al.
Publicado: (2012)